Prothena CMO Hideki Garren departs; Chad Swanson appointed Chief Development Officer

PROTHENA CORP PUBLIC LTD CO

Hideki Garren, M.D., Ph.D., resigns as Chief Medical Officer effective Sept 27, 2024, to lead global product development at a large pharma.
Chad Swanson, Ph.D., promoted to Chief Development Officer; will lead clinical development and medical functions.
Swanson joined Prothena in Jan 2023 from Eisai, where he led the lecanemab program for early Alzheimer's disease.
Prothena will initiate a search for a new Chief Medical Officer.
Swanson will join the executive leadership team and report to CEO Gene Kinney.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Hideki Garren

Chief Medical Officer

PRTA · PROTHENA CORP PUBLIC LTD CO

Effective: 2024-09-27
Filed: September 27, 2024, 7:59 PM ET

On September 23, 2024, Hideki Garren, M.D., Ph.D., Chief Medical Officer of Prothena Corporation plc (the “Company”) notified the Company that he is resigning from the Company effective September 27, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hideki Garren resigned as Chief Medical Officer at PROTHENA CORP PUBLIC LTD CO.

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On September 23, 2024, Hideki Garren, M.D., Ph.D., Chief Medical Officer of Prothena Corporation plc (the “Company”) notified the Company that he is resigning from the Company effective September 27, 2024.

View on SEC.gov

PROTHENA CORP PUBLIC LTD CO filing history →

Source: SEC EDGAR

accession 0001559053-24-000028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.